Dr Michael Salako is Investment Director at Start Codon, an early-stage venture capital fund and venture builder. Previously, he worked for over 10 years at Cancer Research UK, focusing on identifying, developing, transacting, and seed-investing in next-generation oncology programmes and spin-out opportunities.
Michael has a first-class degree in Biochemistry, a PhD in Molecular Virology and Molecular Toxicology, an MBA focused on finance and entrepreneurship, postdoctoral experience in immuno-oncology, drug discovery expertise to Principal Scientist level and is a Certified Licensing Professional. He is the recipient of a number of awards and is active on the life science/healthcare startup scene.